Search

Author/Creator Palmer, Daniel H

12. Prognostic molecular markers in resected extrahepatic biliary tract cancers; a systematic review and meta-analysis of immunohistochemically detected biomarkers. (August 2015)

Authors:
Jones, Robert P; Bird, Nicholas TE; Smith, Richard A; Palmer, Daniel H; Fenwick, Steven W; Poston, Graeme J; Malik, Hassan Z
Journal:
Biomarkers in medicine
Issue:
Volume 9:Number 8(2015)
Page Start:
763
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. Second-line FOLFOX chemotherapy for advanced biliary tract cancer – Authors' reply. Issue 7 (July 2021)

Authors:
Lamarca, Angela; Palmer, Daniel H; Wasan, Harpreet Singh; Ross, Paul J; Ma, Yuk Ting; Arora, Arvind; Falk, Stephen; Gillmore, Roopinder; Wadsley, Jonathan; Patel, Kinnari; Anthoney, Alan; Maraveyas, Anthony; Iveson, Tim; Waters, Justin S; Hobbs, Claire; Barber, Safia; Ryder, W David; Ramage, John...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 7(2021)
Page Start:
e288
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial. Issue 5 (May 2021)

Authors:
Lamarca, Angela; Palmer, Daniel H; Wasan, Harpreet Singh; Ross, Paul J; Ma, Yuk Ting; Arora, Arvind; Falk, Stephen; Gillmore, Roopinder; Wadsley, Jonathan; Patel, Kinnari; Anthoney, Alan; Maraveyas, Anthony; Iveson, Tim; Waters, Justin S; Hobbs, Claire; Barber, Safia; Ryder, W David; Ramage, John...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 5(2021)
Page Start:
690
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial. (August 2017)

Authors:
Meyer, Tim; Fox, Richard; Ma, Yuk Ting; Ross, Paul J; James, Martin W; Sturgess, Richard; Stubbs, Clive; Stocken, Deborah D; Wall, Lucy; Watkinson, Anthony; Hacking, Nigel; Evans, T R Jeffry; Collins, Peter; Hubner, Richard A; Cunningham, David; Primrose, John Neil; Johnson, Philip J; Palmer, Dan...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 2:Number 8(2017)
Page Start:
565
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

17. Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial. Issue 4 (April 2017)

Authors:
Middleton, Gary; Palmer, Daniel H; Greenhalf, William; Ghaneh, Paula; Jackson, Richard; Cox, Trevor; Evans, Anthony; Shaw, Victoria E; Wadsley, Jonathan; Valle, Juan W; Propper, David; Wasan, Harpreet; Falk, Stephen; Cunningham, David; Coxon, Fareeda; Ross, Paul; Madhusudan, Srinivasan; Wadd, Nic...
Journal:
Lancet oncology
Issue:
Volume 18:Issue 4(2017:Apr.)
Page Start:
486
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗